The statistics are frightening: Dementia is the biggest killer in the UK, affecting one in two people. Breakthrough drugs like donanemab and lecanemab offer hope by targeting the root cause of Alzheimer's.
Dementia research is at a critical point with over 140 ongoing clinical trials for Alzheimer's treatments, showing promise in removing toxic proteins and restoring damaged brain cells.
Collection
[
|
...
]